HITI Relative Valuation - High Tide Inc - Alpha Spread
H

High Tide Inc
NASDAQ:HITI

Watchlist Manager
High Tide Inc
NASDAQ:HITI
Watchlist
Price: 2.31 USD 5% Market Closed
Market Cap: 185.8m USD
Have any thoughts about
High Tide Inc?
Write Note
Section:
 

Relative Value

The Relative Value of one HITI stock under the Base Case scenario is 5.05 USD. Compared to the current market price of 2.31 USD, High Tide Inc is Undervalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

HITI Relative Value
Base Case
5.05 USD
Undervaluation 54%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

0.5
P/S
P/S
Price to Sales
0.5
vs History
49
vs Industry
85
Median 3Y
0.4
Median 5Y
0.5
Industry
2.6
Forward
0.5
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5
Median 5Y
-6.4
Industry
22.9
Forward
-87.2
More Details
6.7
P/OCF
P/OCF
Price to OCF
6.7
vs History
53
vs Industry
45
Median 3Y
7.4
Median 5Y
6.7
Industry
17.6
More Details
21.1
P/FCFE
P/FCFE
Price to FCFE
21.1
vs History
20
vs Industry
23
Median 3Y
-6.9
Median 5Y
-6.9
Industry
25.2
More Details
1.8
P/B
P/B
Price to Book Value
1.8
vs History
55
vs Industry
49
Median 3Y
1.2
Median 5Y
1.9
Industry
2.2
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
50
vs Industry
86
Median 3Y
0.5
Median 5Y
0.5
Industry
2.7
Forward
0.5
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
50
vs Industry
76
Median 3Y
1.7
Median 5Y
1.8
Industry
5.4
More Details
6.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
6.4
vs History
65
vs Industry
44
Median 3Y
10.2
Median 5Y
7.5
Industry
13.9
Forward
6.7
More Details
29.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
29.2
vs History
19
vs Industry
18
Median 3Y
-9.5
Median 5Y
-9.5
Industry
17.3
Forward
-46.1
More Details
7
EV/OCF
EV/OCF
Enterprise Value to OCF
7
vs History
57
vs Industry
45
Median 3Y
8.1
Median 5Y
7.7
Industry
16.1
More Details
8.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
8.8
vs History
38
vs Industry
32
Median 3Y
-12
Median 5Y
-12
Industry
18.8
More Details
1.4
EV/IC
EV/IC
Enterprise Value to IC
1.4
vs History
38
vs Industry
53
Median 3Y
1
Median 5Y
1.1
Industry
2
More Details

Multiples Across Competitors

HITI Competitors Multiples
High Tide Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
High Tide Inc
NASDAQ:HITI
183.3m USD 0.5 -7.3 6.4 29.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
843.2B USD 21.7 114.8 57.4 64.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.3 38.2 25.5 29.2
US
Johnson & Johnson
NYSE:JNJ
385.8B USD 4.5 10.1 12.4 16.1
US
Merck & Co Inc
NYSE:MRK
278.3B USD 4.5 20.3 13.7 16.8
CH
Roche Holding AG
SIX:ROG
206.1B CHF 3.5 17.9 10.1 12
UK
AstraZeneca PLC
NASDAQ:AZN
240.2B USD 4.9 37.3 17.1 25.6
CH
Novartis AG
SIX:NOVN
191.2B CHF 4.6 13.8 10.9 16.1
US
Pfizer Inc
NYSE:PFE
162B USD 2.9 -62.4 12.6 20.4
P/E Multiple
Earnings Growth
CA
H
High Tide Inc
NASDAQ:HITI
Average P/E: 36.1
Negative Multiple: -7.3 		N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
114.8
425%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
38.2
90%
US
Johnson & Johnson
NYSE:JNJ
10.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.3
7 419%
CH
Roche Holding AG
SIX:ROG
17.9
30%
UK
A
AstraZeneca PLC
NASDAQ:AZN
37.3
175%
CH
Novartis AG
SIX:NOVN
13.8
19%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -62.4
712%

See Also

Summary
HITI intrinsic value, competitors valuation, and company profile.
DCF Valuation
HITI stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HITI stock valuation using valuation multiples.
Wall Street Estimates
HITI price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HITI stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 184,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.